Congress logo
Back to Conference page

The 13th World Conference on Tobacco OR Health

Building capacity for a tobacco-free world

July 12-15, 2006, Washington, DC, USA



Thursday, July 13, 2006 - 12:00 PM
13-92

Women, Tobacco Use and Chronic Diseases in the Philippines

Marina M. Baquilod, MD, MSc.1, Baltazar Jane C, DrPH2, and Teodora V. Tiglao, EdD2. (1) Department of Health, National Epidemiology Center, 1st Flr., Bldg 9, DOH Compound, Rizal Avenue, Sta. Cruz, Manila, Philippines, (2) University of the Philippines-Manila, Pedro Gil St., Manila, Philippines

Objective: Establish behavioral risk factor levels and prevalence of chronic diseases among Filipino women aged 15 years old and over in the Philippines

Methods: Cross-sectional study among Filipino women aged 15 years old and over done in 2001. A three-stage stratified, cluster sampling design was utilized, all 16 health regions represented. A structured questionnaire modified from CDC's BRFSS was used for household face-to-face interview with a total of 3,738 women respondents.

Results: The prevalence of current tobacco use in the Philippines is 23.5%. About 8% of these current smokers are women. Around 10% had initiated smoking at ages 6-9 years, 14.3% at ages 10-15, 57% at ages 20-24, 19.8% at ages 25-30, and 5.3% at ages 30 and over. Socializing and relieving stress (80%) are reasons for smoking. Cigarette is the major (33%) type of tobacco product smoked. Only a quarter agrees that tobacco products should be advertised. Majority (80-95%) favor ban of tobacco use in public places. Over 95% perceived tobacco use causes chronic disabling diseases. Over half of these women have good perception of their health status, however, 13.2% of women has hypertension, 1.6% had MI, 1.8% has Angina or CAD, 2.0% had stroke, and 2.0 has diabetes. Conclusions: Tobacco use among women in the country is moderately high. Majority had initiated tobacco use at very young age. Tobacco use is a risk factor for chronic disease. A number of Filipino women are suffering from cardiovascular disease, stroke and diabetes.